Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
9.55
+0.14 (1.49%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Puma Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 493 | 300 | 150 | 206 | 196 | 124 | |
Market Cap Growth | 90.78% | 100.26% | -27.32% | 5.07% | 57.73% | -69.53% |
Enterprise Value | 404 | 246 | 139 | 233 | 233 | 154 |
Last Close Price | 9.55 | 5.95 | 3.05 | 4.33 | 4.23 | 3.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.96 | 9.64 | 4.95 | 9.54 | 98021.07 | - |
Forward PE | - | 12.55 | 11.62 | 10.57 | 33.92 | 127.84 |
PS Ratio | 2.13 | 1.31 | 0.65 | 0.87 | 0.86 | 0.49 |
PB Ratio | 3.52 | 2.30 | 1.63 | 3.85 | 9.07 | -50.81 |
P/TBV Ratio | 4.83 | 3.37 | 3.65 | - | - | - |
P/FCF Ratio | 11.98 | 7.19 | 3.85 | 7.67 | - | 6.02 |
P/OCF Ratio | 11.98 | 7.17 | 3.85 | 7.63 | - | 6.02 |
PEG Ratio | - | 25.68 | 25.68 | 25.68 | 25.68 | 25.68 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.75 | 1.08 | 0.61 | 0.99 | 1.02 | 0.61 |
EV/EBITDA Ratio | 10.07 | 5.20 | 3.39 | 5.44 | 5.74 | 12.22 |
EV/EBIT Ratio | 13.27 | 6.61 | 4.50 | 7.14 | 7.58 | 119.32 |
EV/FCF Ratio | 9.81 | 5.91 | 3.59 | 8.68 | - | 7.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.22 | 0.80 | 2.09 | 5.29 | -47.69 |
Debt / EBITDA Ratio | 0.11 | 0.56 | 1.66 | 2.33 | 2.54 | 6.78 |
Debt / FCF Ratio | 0.12 | 0.68 | 1.91 | 4.15 | - | 5.65 |
Net Debt / Equity Ratio | -0.64 | -0.53 | -0.29 | 0.29 | 1.54 | -14.12 |
Net Debt / EBITDA Ratio | -2.22 | -1.45 | -0.65 | 0.36 | 0.82 | 2.74 |
Net Debt / FCF Ratio | -2.16 | -1.65 | -0.69 | 0.58 | -2.10 | 1.67 |
Asset Turnover | 1.19 | 1.06 | 1.04 | 1.04 | 1.02 | 1.08 |
Inventory Turnover | 5.31 | 8.17 | 8.15 | 10.80 | 9.47 | 12.06 |
Quick Ratio | 2.57 | 1.86 | 1.38 | 1.45 | 1.59 | 1.05 |
Current Ratio | 2.91 | 2.00 | 1.54 | 1.57 | 1.73 | 1.28 |
Return on Equity (ROE) | 21.97% | 27.97% | 41.60% | 57.54% | 0.02% | - |
Return on Assets (ROA) | 9.81% | 10.85% | 8.72% | 9.01% | 8.56% | 0.34% |
Return on Invested Capital (ROIC) | 56.55% | 51.23% | 46.14% | 50.21% | 0.16% | 1.04% |
Return on Capital Employed (ROCE) | 21.30% | 27.60% | 26.40% | 24.90% | 21.20% | 1.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.42% | 10.38% | 20.22% | 10.48% | 0.00% | -23.43% |
FCF Yield | 8.35% | 13.92% | 25.96% | 13.04% | -8.07% | 16.61% |
Buyback Yield / Dilution | -3.62% | -3.16% | -3.26% | -5.83% | -10.56% | -2.69% |